Board meeting set for November 5 to approve Q2 and H1 results

Revenue growth above 20%Profit growth above 25%EBITDA margin expansionResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.4%Reaction day

₹342.70

prior close

₹345.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.4%-6.8% vs market

Specialty Chemicals peers, median of 100sector+1.9%-7.3% vs sector

On the reaction day the stock moved 6.8 pts less than Nifty Microcap 250 and 7.3 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.6

10m

-2.9

15m

-1.8

30m

-1.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.4+1.4-6.8+1.9-7.3

Next day

-4.9+1.7-6.6+1.0-5.9

-5.5+3.9-9.4+2.4-7.9

-3.1+5.1-8.2+2.9-6.0

+1.7pendingpending+2.6-0.9

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 100Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Titan Biotech will hold its Board meeting on November 5, 2026 to approve unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The trading window for designated persons has been closed since October 1 and will stay closed until 48 hours after the results are announced.

Likely market impact

The results announcement could affect the share price, but the filing provides no financial figures or indications of performance.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹135.6 Cr	₹54.35 Cr	+149.5%
Operating profit	₹24.33 Cr	₹7.89 Cr	+208.2%
Profit after tax	₹23.40 Cr	₹7.76 Cr	+201.4%
EBITDA margin	20.3%	17.2%	+3.1 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.